Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A
hormonal therapy used in the treatment ofprostate cancer .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word degarelix.
Examples
-
It was launched in the US in March 2009 under the generic name, degarelix.
WN.com - Articles related to Freedom to set prices key for UK drugs industry 2010
-
FIRMAGON® (degarelix for injection), a new injectable prostate cancer medication for the treatment of advanced prostate cancer, is now available in the US The treatment rapidly inhibits the production of testosterone, a hormone that stimulates cancer growth.
WN.com - Articles related to Freedom to set prices key for UK drugs industry 2010
-
It was launched in the US in March 2009 under the generic name, degarelix.
WN.com - Articles related to Freedom to set prices key for UK drugs industry 2010
-
FIRMAGON® (degarelix for injection), a new injectable prostate cancer medication for the treatment of advanced prostate cancer, is now available in the US The treatment rapidly inhibits the production of testosterone, a hormone that stimulates cancer growth.
WN.com - Articles related to Freedom to set prices key for UK drugs industry 2010
-
Food and Drug Administration (FDA) for degarelix, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist, indicated for patients with advanced prostate cancer ...
-
Food and Drug Administration (FDA) for degarelix, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist, indicated for patients with advanced prostate cancer ...
-
During his first six months at Ferring, he restructured the Medical Affairs and Product Safety departments, created a Medical Information department, and was instrumental in the pre-launch activities for newly approved degarelix for injection.
unknown title 2009
-
Food and Drug Administration (FDA) for degarelix, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist, indicated for patients with advanced prostate cancer ...
-
Food and Drug Administration (FDA) for degarelix, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist, indicated for patients with advanced prostate cancer ...
-
Food and Drug Administration (FDA) for degarelix, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist, indicated for patients with advanced prostate cancer ...
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.